Fresenius Medical Care AG (FRA:FMEA)

Market Cap	11.35B -17.5%
Revenue (ttm)	19.64B +2.1%
Net Income	718.19M +9.0%
EPS	2.44 +8.6%
Shares Out	n/a
PE Ratio	15.81
Forward PE	11.22
Dividend	0.51 (2.54%)
Ex-Dividend Date	May 23, 2025

Volume	n/a
Average Volume	71
Open	20.20
Previous Close	20.00
Day's Range	20.20 - 20.20
52-Week Range	17.90 - 27.20
Beta	n/a
RSI	54.27
Earnings Date	Feb 24, 2026

About Fresenius Medical Care AG

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient’s residence; and dialysis services under contract to hospitals in the United States for the hospital...

• Industry: Miscellaneous Health And Allied Services, Not Elsewhere Classified
• Founded: 1996
• Employees: 109,916
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: FMEA

Financial Performance

In 2024, Fresenius Medical Care AG's revenue was 19.34 billion, a decrease of -0.61% compared to the previous year's 19.45 billion. Earnings were 537.91 million, an increase of 7.80%.